Ipratropium, sodium cromoglycate and antihistamines.
Lulich
K M
KM
Department of Pharmacology, University of Western Australia, Perth.
Paterson
J W
JW
Goldie
R G
RG
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy; D002648:Child; D004205:Cromolyn Sodium / Q000494:pharmacology* / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D009241:Ipratropium / Q000494:pharmacology* / Q000627:therapeutic use; D007665:Ketotifen / Q000494:pharmacology / Q000627:therapeutic use; D008168:Lung / Q000187:drug effects / Q000294:innervation; D011976:Receptors, Muscarinic / Q000145:classification / Q000187:drug effects; D011984:Sensory Receptor Cells / Q000187:drug effects; D016593:Terfenadine / Q000494:pharmacology / Q000627:therapeutic use
D006634:Histamine H1 Antagonists; D011976:Receptors, Muscarinic; D016593:Terfenadine; D009241:Ipratropium; D000109:Acetylcholine; D004205:Cromolyn Sodium; D007665:Ketotifen